Literature DB >> 18025133

The future for lung disease in children.

Warren Lenney1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18025133      PMCID： PMC2094289          DOI： 10.1136/thx.2007.090969

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats.

Authors:  Giovanni Piedimonte; Richard G Hegele; Alexander Auais
Journal:  Pediatr Res       Date:  2004-01-07       Impact factor: 3.756

Review 2.  2-5A antisense treatment of respiratory syncytial virus.

Authors:  Douglas W Leaman
Journal:  Curr Opin Pharmacol       Date:  2005-10       Impact factor: 5.547

3.  Local variability in respiratory syncytial virus disease severity.

Authors:  A H Brandenburg; P Y Jeannet; H A Steensel-Moll; A Ott; P H Rothbarth; W Wunderli; S Suter; H J Neijens; A D Osterhaus; C A Siegrist
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

4.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors:  A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

5.  Cystic fibrosis mortality and survival in the UK: 1947-2003.

Authors:  J A Dodge; P A Lewis; M Stanton; J Wilsher
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

Review 6.  Leptin, obesity, and respiratory function.

Authors:  C P O'Donnell; C G Tankersley; V P Polotsky; A R Schwartz; P L Smith
Journal:  Respir Physiol       Date:  2000-02

Review 7.  Respiratory syncytial virus infection.

Authors:  E A Simoes
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

Review 8.  Palivizumab for preterm infants. Is it worth it?

Authors:  N D Embleton; C Harkensee; M C Mckean
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-07       Impact factor: 5.747

9.  Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy.

Authors:  P Pala; R Bjarnason; F Sigurbergsson; C Metcalfe; N Sigurs; P J M Openshaw
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

Review 10.  Advances in respiratory syncytial virus vaccine development.

Authors:  Martin C J Kneyber; Jan L L Kimpen
Journal:  Curr Opin Investig Drugs       Date:  2004-02
  10 in total
  1 in total

1.  In Vitro Determination of Respimat® Dose Delivery in Children: An Evaluation Based on Inhalation Flow Profiles and Mouth-Throat Models.

Authors:  Deborah Bickmann; Wolfgang Kamin; Ashish Sharma; Herbert Wachtel; Petra Moroni-Zentgraf; Stefan Zielen
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-06-22       Impact factor: 2.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.